Literature DB >> 24242177

An automatic reaction control chemical ionization technique in ion trap detector for quantitative plasma profding of arecoline in treated alzheimer patients.

H U Shetty1, E M Daly, N H Greig, S I Rapoport, T T Soncrant.   

Abstract

An automatic reaction control chemical ionization technique in an ion trap detector (lTD) was used to quantitate the levels of the cholinergic drug, arecoline, in plasma of treated patients with Alzheimer's disease. The chemical ionization reaction was carried out with acetonitrile. The protonated molecules of arecoline (m I z 156) and the internal standard, homoarecoline (m / z 170), were monitored. Human plasma samples were extracted with a readily evaporable solvent mixture, the residues reconstituted and injected along with a tertiary amine-carrier into a capillary gas chromatograph interfaced with the ITD. Standard curves for plasma-extracted arecoline between 20-ng/mL and 156-pg/mL levels were linear (r> 0.9980). Satisfactory precision (relative standard deviation < 20%) and accuracy (relative error < 15%) at the limit of quantitation, 156 pg/mL arecoline, were achieved. Optimal conditions for handling of blood samples obtained by venipuncture were determined. The assay was successfully applied for the therapeutic monitoring of Alzheimer patients treated intravenously with arecoline.

Entities:  

Year:  1991        PMID: 24242177     DOI: 10.1016/1044-0305(91)80011-U

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  11 in total

1.  Quantitative determination of arecoline in plasma by gas chromatography chemical ionization mass spectrometry.

Authors:  M J Hayes; L Khemani; M Bax; D Alkalay
Journal:  Biomed Environ Mass Spectrom       Date:  1989-11

2.  [On the pharmacology of active materials from betel. 2. Transformation of arecoline to arecaidine].

Authors:  O Nieschulz; P Schmersahl
Journal:  Arzneimittelforschung       Date:  1968-02

Review 3.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

4.  Cell loss from the nucleus basalis of Meynert in Alzheimer's disease.

Authors:  R Doucette; M Fisman; V C Hachinski; H Mersky
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

5.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

Authors:  P J Whitehouse; D L Price; R G Struble; A W Clark; J T Coyle; M R Delon
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

6.  Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.

Authors:  T D Bird; S Stranahan; S M Sumi; M Raskind
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

7.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25

8.  Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.

Authors:  S Lehéricy; E C Hirsch; P Cervera; L B Hersh; J J Hauw; M Ruberg; Y Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia.

Authors:  J E Christie; A Shering; J Ferguson; A I Glen
Journal:  Br J Psychiatry       Date:  1981-01       Impact factor: 9.319

10.  Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.

Authors:  R Quirion; J C Martel; Y Robitaille; P Etienne; P Wood; N P Nair; S Gauthier
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

View more
  5 in total

1.  Quantitative analysis of crude plasma extracts by ion trap tandem mass spectrometry.

Authors:  R J Strife; J R Simms
Journal:  J Am Soc Mass Spectrom       Date:  1992-05       Impact factor: 3.109

Review 2.  Potential role of muscarinic agonists in Alzheimer's disease.

Authors:  E E Avery; L D Baker; S Asthana
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

Authors:  T T Soncrant; K C Raffaele; S Asthana; A Berardi; P P Morris; J V Haxby
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 4.  Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review.

Authors:  Nuno G Oliveira; Daniela L Ramos; Ricardo Jorge Dinis-Oliveira
Journal:  Arch Toxicol       Date:  2020-10-24       Impact factor: 5.153

5.  Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.

Authors:  S Genka; J Deutsch; U H Shetty; P L Stahle; V John; I M Lieberburg; F Ali-Osman; S I Rapoport; N H Greig
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.